Also known as

Fonturacetam hydrazide · Phenylpiracetam hydrazide · Racetam analog (not a peptide)

Overview

Phenylpiracetam hydrazide is a modified phenylpiracetam analog studied in cognitive and stimulant-class research. It is a racetam-related small molecule, not a peptide, appearing on some nootropic research lists.

Endpoints in literature and vendor notes center on alertness, learning-task, and stimulant-adjacent behavioral markers. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Cognitive and learning-task endpoints in research models

• • Stimulant-class alertness and locomotor markers

• • Racetam-analog pharmacology versus parent phenylpiracetam

• • Cold/stress performance co-markers where historically studied

• • Comparative nootropic small-molecule research framing

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

• Week 1–2: Early signaling and behavioral endpoints in acute neuro models; exposure establishing.

• • Week 3–4: Clearer cognitive, stress, or neuroprotective markers in short research windows.

• • Month 2–3: More stable memory, focus, or neuroplasticity-related endpoints in extended designs.

• • Month 3–6: Sustained neuro and aging-adjacent observations where longer protocols are used.

Footer RUO

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.